ABSENCE OF A SIGNIFICANT PHARMACOKINETIC INTERACTION BETWEEN HYDROCHLOROTHIAZIDE AND TRIAMTERENE WHEN COADMINISTERED

被引：13

作者：

UPTON, RA ^{[1
]}

WILLIAMS, RL ^{[1
]}

LIN, ET ^{[1
]}

GEE, WL ^{[1
]}

BLUME, CD ^{[1
]}

BENET, LZ ^{[1
]}

机构：

[1] MYLAN PHARMACEUT INC,MORGANTOWN,WV 26505

来源：

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1984年 / 12卷 / 06期

关键词：

D O I：

10.1007/BF01059553

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：575 / 586

页数：12

共 10 条

[1]

BEERMANN B, 1980, CLIN PHARMACOKINET, V5, P221, DOI 10.2165/00003088-198005030-00003

[2] BIOEQUIVALENCE STUDY OF A NEW TABLET FORMULATION OF TRIAMTERENE AND HYDROCHLOROTHIAZIDE [J].

BLUME, CD ;

WILLIAMS, RL ;

UPTON, RA ;

LIN, ET ;

BENET, LZ .

AMERICAN JOURNAL OF MEDICINE, 1984, 77 (5A) :59-61

[3]

HANSEN KB, 1966, CLIN PHARM THER, V8, P392

[4]

LIN ET, 1984, CLIN LIQUID CHROMATO, V1, P115

[5] PHARMACOKINETICS OF HYDROCHLOROTHIAZIDE IN RELATION TO RENAL-FUNCTION [J].

NIEMEYER, C ;

HASENFUSS, G ;

WAIS, U ;

KNAUF, H ;

SCHAFERKORTING, M ;

MUTSCHLER, E .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (05) :661-665

[6] PRELIMINARY-OBSERVATIONS ON DISSOLUTION AND BIOAVAILABILITY OF TRIAMTERENE HYDROCHLOROTHIAZIDE COMBINATION PRODUCTS [J].

SHAH, VP ;

WALKER, MA ;

PRASAD, VK ;

LIN, J ;

KNAPP, G ;

CABANA, BE .

BIOPHARMACEUTICS & DRUG DISPOSITION, 1984, 5 (01) :11-19

[7] LIQUID-CHROMATOGRAPHIC ANALYSIS OF TRIAMTERENE AND ITS MAJOR METABOLITE, HYDROXYTRIAMTERENE SULFATE, IN BLOOD, PLASMA, AND URINE [J].

SORGEL, F ;

LIN, ET ;

HASEGAWA, J ;

BENET, LZ .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (06) :831-833

[8] POTASSIUM-SPARING EFFECTS OF TRIAMTERENE IN TREATMENT OF HYPERTENSION [J].

SPIEKERMAN, RE ;

BERGE, KG ;

THURBER, DL ;

GEDGE, SW ;

MCGUCKIN, WF .

CIRCULATION, 1966, 34 (03) :524-+

[9]

TANNENBAUM PJ, 1968, CLIN PHARMACOL THER, V9, P598

[10]

1959, METROPOLITAN LIF NOV

← 1 →